ISPOR Summit 2019 Will Focus on Real-World Evidence Transparency Initiative

Examining the Role of Study Registration in Building Trust in Real-World Evidence

Lawrenceville, NJ, USA—August 19, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), announced plans for its ISPOR Summit 2019 scheduled for October 11, 2019 in Baltimore, MD, USA. The Summit, “Building Trust in Real-World Evidence: The Role of Study Registration,” will provide a forum for discussion of the Real-World Evidence Transparency Initiative, led by ISPOR, International Society for Pharmacoepidemiology (ISPE), Duke-Margolis Center for Health Policy, National Pharmaceutical Council (NPC), and a number of other organizations and stakeholders.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: , , , , ,

ISPOR Latin America 2019 Announces Program Focused on Data and Value in Healthcare

1000+ HEOR Stakeholders Will Convene in Bogotá, Colombia on 12-14 September

Lawrenceville, NJ, USA—August 13, 2019—ISPOR—the professional society for health economics and outcomes research (HEOR)—announced plenary sessions and speakers for its ISPOR Latin America 2019 conference. The leading HEOR conference in Latin America will focus on “Data and Value in Healthcare: 2020 and Beyond” on 12-14 September 2019 in Bogotá, Colombia.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with: ,

ISPOR Awarded Multiple dotCOMM Awards

Society’s Branding, Annual Report, and Website Honored for Excellence

Lawrenceville, NJ, USA—August 12, 2019—ISPOR—the professional society for health economics and outcomes research announced that it has been awarded multiple dotCOMM awards recognizing its new branding, annual report, and website redesign.

Read more ›
Posted in Announcements, ISPOR News & Press Tagged with:

ISPOR’s Nancy S. Berg Named a PharmaVOICE Red Jacket Honoree

Lawrenceville, NJ, USA—August 5, 2019—ISPOR, the professional society for health economics and outcomes research, announced that its CEO and Executive Director Nancy S. Berg has been named a 2019 PharmaVOICE Red Jacket Award honoree.

Ms Berg has led ISPOR since 2014. She is being recognized for her strategic leadership of ISPOR and her ability to forge collaborative and productive relationships that further the Society’s mission to promote health economics and outcomes research (HEOR) excellence to improve decision making for health globally.

In collaboration with ISPOR’s board of directors, Ms Berg has achieved a number of accomplishments and launched key initiatives that have contributed to ISPOR becoming the leading professional society for HEOR globally. During her tenure, the Society has grown to 20,000+ individual and chapter members globally, increased attendance at its global HEOR conferences to more than 11,000 delegates in 2018, augmented its investment in mission-critical initiatives (such as programs in low- and middle-income countries) to $4.3 million US, launched its Health Technology Assessment Central, formed its new Patient Council, updated its corporate branding, and undertaken a massive IT project introducing key internal platforms to better serve its members.

PharmaVOICE describes its Red Jacket Award as their “version of a Hall of Fame” and introduced the award 5 years ago at the 10thanniversary of its PharmaVOICE 100 awards that annually celebrates the most inspiring leaders in healthcare. Red Jacket honorees are previously recognized PharmaVOICE 100 awardees who have “raised the bar in terms of what it means to be an inspiring leader” and are selected based on a number of criteria, including (a) for challenging us to think differently, act differently, and lead differently; (b) for creating new opportunities to make what was once impossible—possible; (c) for focusing beyond short-term gains and committing to executing their long-term visions in a tightly regulated and competitive industry; (d) for having a persistence of vision; and (e) for truly transforming the life-sciences industry to create better health outcomes for all.

Additional information on the Red Jacket Awards can be found here. The 2019 PharmaVOICE 100 list can be found here.

###

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

Posted in Announcements, ISPOR News & Press Tagged with: ,

Applying Machine Learning to Healthcare Outcomes Research

Global Experts Demonstrate Common Machine Methods in Value in Health

Lawrenceville, NJ, USA—July 16, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a high-level overview of machine learning for healthcare outcomes researchers and decision makers. The report, “Machine Learning for Health Services Researchers,” was published in the July 2019 issue of Value in Health.

Read more ›
Posted in Announcements, ISPOR News & Press, Value in Health Tagged with: , , , ,

Implementation of “Coverage With Evidence Development” Drug Approval Strategies Found Lacking

Lessons from Early Deployments in The Netherlands

Lawrenceville, NJ, USA—July 15, 2019—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research from The Netherlands showing important gaps in the deployment of “coverage with evidence development,” a type of pharmaceutical managed entry agreement that gives patients access to treatments while additional evidence is being collected. The report, “Uncertainty and Coverage With Evidence Development: Does Practice Meet Theory?” was published in the July 2019 issue of Value in Health.

Read more ›
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , ,

ISPOR Launches Expanded HEOR Presentations Database

New Presentations Database Offers a Comprehensive, Searchable Resource

Lawrenceville, NJ, USA—July 9, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), launched an expanded, enhanced HEOR resource—the ISPOR Presentations Database.

Read more ›
Posted in Announcements, ISPOR News & Press

Healthcare Experts Debate New Methods of Assessing the Value of Prescription Drugs, Medical Devices, and Procedures

Value in Health Supplement Reports Findings of Third Annual ISPOR Summit

Lawrenceville, NJ, USA—June 18, 2019—Value in Health, the official journal of ISPOR, the professional society for health economics and outcomes research, announced today the publication of a new supplement, “New Approaches to Value Assessment: Towards More Informed Pricing in Healthcare.” The 6 articles included in this supplement are based on presentations from the Third Annual ISPOR Summit held in Washington, DC, USA on October 19, 2018. Full text of the articles is freely available online and the supplement will be indexed in MEDLINE®/PubMed. The supplement, which was published in June 2019 along with the regular issue of Value in Health, extends the reach and expands access to important discussions about how healthcare stakeholders in the United States are assessing value in healthcare today and into the future.

Read more ›
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , , , , , ,

A Beginner’s Guide to Understanding Curative Therapies

Value in Health Themed Section Offers Updated Perspective

Lawrenceville, NJ, USA—June 17, 2019—Value in Health, the official journal of ISPOR, the professional society for health economics and outcomes research, announced today the publication of a series of articles offering important insight regarding the current state of curative and transformative therapies. The special themed section appears in the June 2019 issue of Value in Health. Guest editors for the themed section are Don Husereau, BSc Pharm, MSc, University of Ottawa, Ottawa, ON, Canada, and Shelby D. Reed, RPh, PhD, Duke University, Durham, NC, USA.

Read more ›
Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR Board of Directors Approves New Diversity and Inclusion Policy

Lawrenceville, NJ, USA—June 11, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), announced the approval of the Society’s new Diversity and Inclusion Policy.

Read more ›
Posted in Announcements, ISPOR News & Press, Uncategorized Tagged with: , , ,